Awarded Grants

The ODC offers over 50 grant opportunities in 30+ disease areas annually to researchers across the globe, as well as within the Penn and CHOP communities. Since 2011, our grant programs have funded $17.2 million in rare disease research.

See below for a complete list of ODC-awarded grants since 2011.

Click HERE for the full list of 2020 CDKL5 Pilot Grant Programme

Awarded Grants

Displaying Results 31 - 40 of 262

Awardee Project Title Institution Grant Amount Funding Year
Lisa Young Genetic Mechanisms in Neuroendocrine cell Hyperplasia of Infancy (NEHI) The Children's Hospital of Philadelphia MDBR - NEHI $60,989 2020
Marni Falk Pre-clinical animal model and cell evaluation of candidate therapies for human NUBPL disease. Children's Hospital of Philadelphia and University of Pennsylvania MDBR - NUBPL $61,134 2020
Andrew Kennedy Tissue-specific and temporal reinstatement of Tcf4 to treat Pitt-Hopkins Syndrome Bates College MDBR - Pitt Hopkins $68,709 2020
Carl Ernst SETBP1 deficiency syndrome as an AKT modifer in human neurons McGill Uniersity (Douglas Hospital Research Institute) MDBR - SETBP1 $67,943 2020
Robert A. Casero, Jr. Dimethylspermine (Me2Spm) as a novel treatment approach to restore normal spermidine/spermine ratios in Snyder-Robinson Syndrome (SRS) models Johns Hopkins School of Medicine MDBR - SRS $69,318 2020
Matthijs Verhage Rapid and unbiased in vivo screen for lead compounds that rescue STXBP1 dysfunction and subsequent in vitro validation in human neurons Vrije Universiteit Amsterdam MDBR - STXBP1 $69,588 2020
Zachary Grinspan Phenylbutyrate for STXBP1 Encephalopathy – A Pilot Study Weill Cornell Medicine MDBR - STXBP1 $69,588 2020
Thomas Smith Towards new therapeutic treatments for the hyperinsulinism/hyperammonemia syndrome (HI/HA) University of Texas Medical Branch MDBR - CHI $72,014 2020
Nicole Van Bergen What are the functional consequences of CDKL5 dysfunction in human neuronal cells? Murdoch Children's Research Institute MDBR - CDKL5 $55,898 2020
Gregor Andelfinger MEK inhibition for RASopathy associated hypertrophic cardiomyopathy CHU Sainte Justine Research Center, Université de Montréal MDBR - RASopathies $59,220 2020
1 2 3 4 5 6 27